Stay up to date with the latest developments in therapeutics by reading the world's most respected source of authoritative drug information. For 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
Sprache
Kündigungshinweis
30. September des laufenden Jahres
Katalogdaten von NEWBOOKS Solutions GmbH (Köln)
Schweitzer Klassifikation